By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Belgian startup Pepric announced recently it had completed a €1.4 million ($1.8 million) financing round.

The company, a spinout of Imec, said the money will be used to support the production and commercialization of its first product, a tool for quantitative molecular and cellular detection in tissue, urine, and blood samples. Additionally, the funds will go toward the development of Pepric's core in vivo detection technology.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.